A Safety and Tolerability Study of Topical PAT-001 in Congenital Ichthyosis

Condition: Congenital Ichthyosis Interventions: Drug: PAT-001, 0.1%; Drug: PAT-001, 0.2%; Drug: Vehicle Sponsor: Patagonia Pharmaceuticals, LLC Not yet recruiting - verified August 2016

http://clinicaltrials.gov/ct2/show/NCT02864082?lup_s=07%2F16%2F2016&lup_d=30

Source: ClinicalTrials.gov - August 3, 2016 Category: Research Source Type: clinical trials

More News: Ichthyosis | Research | Study